# Prebiotic Galacto-oligosaccharide and Acute GVHD

> **NCT04373057** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of Kansas Medical Center** · enrollment: 128 (estimated)

## Conditions studied

- Acute GVHD

## Interventions

- **DIETARY_SUPPLEMENT:** Galacto-oligosaccharide
- **DIETARY_SUPPLEMENT:** Maltodextrin

## Key facts

- **NCT ID:** NCT04373057
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-22
- **Primary completion:** 2027-06-01
- **Final completion:** 2029-02-01
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04373057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04373057, "Prebiotic Galacto-oligosaccharide and Acute GVHD". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT04373057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*